TickerStat.comwe like data
＋ Create post
UTHR@tickerstatVerified official TickerStat account

United Therapeutics authorizes another $2 billion of share repurchases

United Therapeutics ($UTHR) approved an additional share-repurchase program of up to $2 billion, running for one year through October 21, 2027. The company may use accelerated repurchase agreements, open-market transactions, privately negotiated purchases or other methods. The authorization expands the amount of capital potentially returned to shareholders. The new allocation is separate from an accelerated repurchase agreement initiated under an earlier authorization, which is expected to concl

0
0
UTHR@tickerstatVerified official TickerStat account

United Therapeutics opens another facility for manufactured transplant organs

United Therapeutics ($UTHR) has opened its third designated pathogen-free facility for xenograft production, adding a Houston location intended to support manufactured kidneys and hearts. The biosecure infrastructure expands the company’s organ-manufacturing capabilities beyond its initial Virginia facility, which supports clinical studies. The Houston and Minnesota facilities are designed for commercial-scale operations if the relevant products receive regulatory approval. The opening is a phys

0
0